EUVIMEDEUVIMED entdecken
Crossref

Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosis

Nelson George, Simon Chu, Stephanie Manning, Kai-Zheong Lim, Michael Mond, Ernest Tay, Bhargavi Yellapu, Kate Jones, Andrew Fellowes, Beena Kumar, Jonathan Serpell, Simon Grodski und 3 weitere

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Nelson George und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hormone Cancer Therapeutics, Hudson Institute of Medical Research, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Thyroid Nodule, Proto-Oncogene Proteins B-raf, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Institute for Mental and Physical Health and Clinical Translation, ImPACT Applications.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with indeterminate thyroid nodules continue to be a challenge to clinicians. Molecular testing on fine needle aspirates (FNA) is well established in the United States, but its access is limited elsewhere. We aimed to explore the utility of a pre-existing Next Generation Sequencing (NGS) platform, and the role of BRAF mutation in patient selection for preoperative molecular testing. METHODS: Patients were recruited from the Monash University Endocrine Surgery Database for BRAF immunohistochemistry status on histopathological samples; and prospectively for NGS testing of preoperative FNA samples, using the Archer DX VariantPlex (31 genes) and FusionPlex (40 genes) Comprehensive Thyroid and Lung panels. RESULTS: The mean age of 90 patients (103 nodules) for NGS testing was 53, with 58 % female. Most of the nodules (n = 72, 70 %) had indeterminate cytology. Histology showed malignancy in 52 (50 %) nodules; of these, 45 had pathogenic DNA mutations and 3 had pathogenic RNA fusions on NGS testing of needle aspirates. The NGS panels were able to detect malignancy in indeterminate nodules with 75 % sensitivity, 85 % specificity, 80 % positive predictive value, and 81 % negative predictive value. 74 % of the papillary thyroid cancer population had BRAF mutations on immunohistochemistry, which showed 88 % concordance with the NGS results. CONCLUSION: This is the first Australian study to demonstrate that pre-existing, non-proprietary NGS mutation and fusion panels can achieve high diagnostic specificity and positive predictive value for malignancy in indeterminate thyroid nodules. Furthermore, we propose exploration of using BRAF V600E testing to select patients for full NGS analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NoduleProto-Oncogene Proteins B-rafThyroid NeoplasmsHumansBiopsy, Fine-NeedleFemaleMiddle AgedMaleHigh-Throughput Nucleotide SequencingAdultAgedMutationProspective StudiesSensitivity and SpecificityPredictive Value of TestsImmunohistochemistryAged, 80 and over

Stichwörter der Autor:innen

BRAFFine needle aspiratesIndeterminate cytologyNext generation sequencingThyroid nodules

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Hormone Cancer Therapeutics, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Monash University Endocrine Surgery Unit, Alfred Health, Melbourne, Victoria, Australia.
  • Monash University Endocrine Surgery Unit, Alfred Health, Melbourne, Victoria, Australia; Department of General Surgery, Monash Health, Clayton, Victoria, Australia.
  • Hormone Cancer Therapeutics, Hudson Institute of Medical Research, Clayton, Victoria, Australia; Department of Endocrinology, Monash Health, Clayton, Victoria, Australia.
  • Department of General Surgery, Monash Health, Clayton, Victoria, Australia.
  • Epworth HealthCare, Melbourne, Victoria, Australia.

Förderung

  • Institute for Mental and Physical Health and Clinical Translation
  • ImPACT Applications

Zitieren

APA

George, N., Chu, S., Manning, S., Lim, K. Z., Mond, M., Tay, E., Yellapu, B., Jones, K., Fellowes, A., Kumar, B., Serpell, J., Grodski, S., Shackleton, M., Yannakou, C. K., & Lee, J. C. (2025). Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110082

Vancouver

George N, Chu S, Manning S, Lim KZ, Mond M, Tay E, et al. Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosis. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110082

BibTeX
@article{George2025,
  author = {George, Nelson and Chu, Simon and Manning, Stephanie and Lim, Kai-Zheong and Mond, Michael and Tay, Ernest and Yellapu, Bhargavi and Jones, Kate and Fellowes, Andrew and Kumar, Beena and Serpell, Jonathan and Grodski, Simon and Shackleton, Mark and Yannakou, Costas K and Lee, James C},
  title = {Tiered approach to molecular testing of thyroid fine needle aspiration samples may improve preoperative diagnosis},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110082}
}
Kostenlos starten →